Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 38 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Brucella melitensis bacteraemia with lymphoma-like generalised lymphadenopathy and probable secondary haemophagocytic lymphohistiocytosis under biopsy constraints: a case report

  1. 1First Clinical Medical College of Shandong University of Traditional Chinese Medicine
  2. 2ZiBo 148 Hospital, China RongTong Medical Healthcare Group Co. Ltd.
  3. 3Department of Hematology, Weifang Traditional Chinese Medicine Hospital

Abstract

Background: Brucellosis can resemble lymphoma when lymphadenopathy accompanies cytopenias and systemic inflammation. Associated secondary haemophagocytic lymphohistiocytosis (HLH) adds to the diagnostic difficulty.

Case presentation: A 68-year-old man presented with anorexia, generalised lymphadenopathy, splenomegaly, cytopenias, and hepatic and renal dysfunction. Fever developed on the first hospital evening and reached 41 °C on day 2. Empirical antibiotics and corticosteroids were started before microbiological confirmation. Severe thrombocytopenia complicated biopsy planning, and the patient declined tissue sampling because of financial hardship and concern about physical harm. Blood cultures collected on day 2 yielded Brucella melitensis , reported on day 6. Doxycycline and rifampicin were started, and methylprednisolone was continued. Five HLH-2004 criteria and a retrospective HScore of 234 supported probable secondary HLH. Fever and some laboratory abnormalities improved during empirical treatment, but cytopenias persisted at discharge on day 10. Follow-up blood tests approximately 1 month after discharge showed recovery of white-cell, neutrophil and platelet counts to reference ranges, although anaemia persisted. At approximately 15 months, the patient reported feeling well but declined further laboratory testing and imaging.

Conclusion: Blood cultures identified B. melitensis infection in a patient with lymphoma-like findings and probable secondary HLH. Microbiological identification and serial assessment guided treatment when tissue sampling was declined.

Related

  1. Autochthonous tick-borne lymphadenopathy (TIBOLA) in a 3-year-old child caused by Rickettsia slovaca in southwestern Germany
    Anne Isaak, Dennis Tappe, Alexandra Veit +1
    InfectionPeer-reviewedCC BY 4.0Full textMicrobiologyPMC
  2. Editorial: The expanding spectrum of hemophagocytic lymphohistiocytosis: pathogenic mechanisms and therapeutic implications
    Tiziana Lorenzini, Ola Sabet, Yasmine El Chazli +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
  3. Commentary: Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management
    Gauthier Coussement, Maxime Ilzkovitz, Loïc Baudelet +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  4. Is endobronchial ultrasound-guided bronchoscopy (EBUS) transbronchial needle aspiration (TBNA) enough for the diagnosis of mediastinal lymphadenopathy? A cohort analysis
    Kimberly Taha, Patrice Roll, Julie Tronchetti +2
    Respiratory Medicine and ResearchPeer-reviewedCC BY 4.0Full textGeneral biologyOncologyHAL
  5. Case Report: Fulminant aggressive NK-cell leukemia with hemophagocytic lymphohistiocytosis and multiple organ dysfunction successfully bridged to allogeneic hematopoietic stem cell transplantation
    Shutan Li, Chao Fang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossref
BibTeX
@article{liu2026brucella,
  title = {{Brucella melitensis bacteraemia with lymphoma-like generalised lymphadenopathy and probable secondary haemophagocytic lymphohistiocytosis under biopsy constraints: a case report}},
  author = {Xiaoqi Liu and Anning Song and Mingxia Li and Juning Ma and Qinglin Wang and Jing Yang},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1975515},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1975515/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Brucella melitensis bacteraemia with lymphoma-like generalised lymphadenopathy and probable secondary haemophagocytic lymphohistiocytosis under biopsy constraints: a case report
AU  - Xiaoqi Liu
AU  - Anning Song
AU  - Mingxia Li
AU  - Juning Ma
AU  - Qinglin Wang
AU  - Jing Yang
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1975515
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1975515/full
AB  - Background: Brucellosis can resemble lymphoma when lymphadenopathy accompanies cytopenias and systemic inflammation. Associated secondary haemophagocytic lymphohistiocytosis (HLH) adds to the diagnostic difficulty.  Case presentation: A 68-year-old man presented with anorexia, generalised lymphadenopathy, splenomegaly, cytopenias, and hepatic and renal dysfunction. Fever developed on the first hospital evening and reached 41 °C on day 2. Empirical antibiotics and corticosteroids were started before microbiological confirmation. Severe thrombocytopenia complicated biopsy planning, and the patient declined tissue sampling because of financial hardship and concern about physical harm. Blood cultures collected on day 2 yielded Brucella melitensis , reported on day 6. Doxycycline and rifampicin were started, and methylprednisolone was continued. Five HLH-2004 criteria and a retrospective HScore of 234 supported probable secondary HLH. Fever and some laboratory abnormalities improved during empirical treatment, but cytopenias persisted at discharge on day 10. Follow-up blood tests approximately 1 month after discharge showed recovery of white-cell, neutrophil and platelet counts to reference ranges, although anaemia persisted. At approximately 15 months, the patient reported feeling well but declined further laboratory testing and imaging.  Conclusion: Blood cultures identified B. melitensis infection in a patient with lymphoma-like findings and probable secondary HLH. Microbiological identification and serial assessment guided treatment when tissue sampling was declined.
SN  - 1664-3224
ER  -